Your browser doesn't support javascript.
loading
KDM1A inactivation causes hereditary food-dependent Cushing syndrome.
Vaczlavik, Anna; Bouys, Lucas; Violon, Florian; Giannone, Gaetan; Jouinot, Anne; Armignacco, Roberta; Cavalcante, Isadora P; Berthon, Annabel; Letouzé, Eric; Vaduva, Patricia; Barat, Maxime; Bonnet, Fidéline; Perlemoine, Karine; Ribes, Christopher; Sibony, Mathilde; North, Marie-Odile; Espiard, Stéphanie; Emy, Philippe; Haissaguerre, Magalie; Tauveron, Igor; Guignat, Laurence; Groussin, Lionel; Dousset, Bertrand; Reincke, Martin; Fragoso, Maria C; Stratakis, Constantine A; Pasmant, Eric; Libé, Rossella; Assié, Guillaume; Ragazzon, Bruno; Bertherat, Jérôme.
Afiliação
  • Vaczlavik A; Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, Paris, France; Department of Endocrinology and National Reference Center for Rare Adrenal Disorders, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Bouys L; Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, Paris, France.
  • Violon F; Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, Paris, France; Department of Pathology, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Giannone G; Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, Paris, France.
  • Jouinot A; Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, Paris, France; Department of Endocrinology and National Reference Center for Rare Adrenal Disorders, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, France; Institut Curie, INSERM U900, MINES ParisTech, PSL-Research Univ
  • Armignacco R; Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, Paris, France.
  • Cavalcante IP; Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, Paris, France.
  • Berthon A; Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, Paris, France.
  • Letouzé E; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, INSERM, Paris France.
  • Vaduva P; Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, Paris, France; Department of Endocrinology, Diabetology and Nutrition, CHU Rennes, Rennes, France.
  • Barat M; Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, Paris, France; Department of Radiology, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Bonnet F; Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, Paris, France; Unit of Hormonology, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Perlemoine K; Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, Paris, France.
  • Ribes C; Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, Paris, France.
  • Sibony M; Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, Paris, France; Department of Pathology, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, France.
  • North MO; Unit of Oncogenetics, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Espiard S; Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, Paris, France; Department of Endocrinology, Diabetology, Metabolism and Nutrition, CHU Lille, Lille, France.
  • Emy P; Department of Endocrinology, CHR Orleans, Orléans, France.
  • Haissaguerre M; Department of Endocrinology, University of Bordeaux and CHU Bordeaux, Bordeaux, France.
  • Tauveron I; Department of Endocrinology, CHU Clermont Ferrand, Clermont-Ferrand, France.
  • Guignat L; Department of Endocrinology and National Reference Center for Rare Adrenal Disorders, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Groussin L; Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, Paris, France; Department of Endocrinology and National Reference Center for Rare Adrenal Disorders, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Dousset B; Department of Digestive and Endocrine Surgery, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Reincke M; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
  • Fragoso MC; Department of Endocrinology, Adrenal Unit, University of Sao Paulo, Sao Paulo, Brazil.
  • Stratakis CA; Section on Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (NIH), Bethesda, MD.
  • Pasmant E; Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, Paris, France; Unit of Oncogenetics, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Libé R; Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, Paris, France; Department of Endocrinology and National Reference Center for Rare Adrenal Disorders, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Assié G; Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, Paris, France; Department of Endocrinology and National Reference Center for Rare Adrenal Disorders, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Ragazzon B; Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, Paris, France.
  • Bertherat J; Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, Paris, France; Department of Endocrinology and National Reference Center for Rare Adrenal Disorders, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, France. Electronic address: jerome.bertherat@aphp.fr.
Genet Med ; 24(2): 374-383, 2022 02.
Article em En | MEDLINE | ID: mdl-34906447
ABSTRACT

PURPOSE:

This study aimed to investigate the genetic cause of food-dependent Cushing syndrome (FDCS) observed in patients with primary bilateral macronodular adrenal hyperplasia (PBMAH) and adrenal ectopic expression of the glucose-dependent insulinotropic polypeptide receptor. Germline ARMC5 alterations have been reported in about 25% of PBMAH index cases but are absent in patients with FDCS.

METHODS:

A multiomics analysis of PBMAH tissues from 36 patients treated by adrenalectomy was performed (RNA sequencing, single-nucleotide variant array, methylome, miRNome, exome sequencing).

RESULTS:

The integrative analysis revealed 3 molecular groups with different clinical features, namely G1, comprising 16 patients with ARMC5 inactivating variants; G2, comprising 6 patients with FDCS with glucose-dependent insulinotropic polypeptide receptor ectopic expression; and G3, comprising 14 patients with a less severe phenotype. Exome sequencing revealed germline truncating variants of KDM1A in 5 G2 patients, constantly associated with a somatic loss of the KDM1A wild-type allele on 1p, leading to a loss of KDM1A expression both at messenger RNA and protein levels (P = 1.2 × 10-12 and P < .01, respectively). Subsequently, KDM1A pathogenic variants were identified in 4 of 4 additional index cases with FDCS.

CONCLUSION:

KDM1A inactivation explains about 90% of FDCS PBMAH. Genetic screening for ARMC5 and KDM1A can now be offered for most PBMAH operated patients and their families, opening the way to earlier diagnosis and improved management.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Prevencao_e_fatores_de_risco / Alimentacao / Hereditariedade Base de dados: MEDLINE Assunto principal: Síndrome de Cushing Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Genet Med Assunto da revista: GENETICA MEDICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Prevencao_e_fatores_de_risco / Alimentacao / Hereditariedade Base de dados: MEDLINE Assunto principal: Síndrome de Cushing Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Genet Med Assunto da revista: GENETICA MEDICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França